For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
What Trump’s vaccine executive order actually does
Yesterday, President Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations, reducing the number of vaccines recommended for…
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Search Posts
National Review
Evicting the Constitution
Few government actions have been more emblematic of bureaucratic overreach than the Centers for Disease Control and Prevention’s nationwide eviction moratorium. After multiple successful…
New York Post
Hasty About-Face Distorts Delta Force
The CDC now urges public indoor masking after a worrisome study on the Delta variant — undermining the vaccine effort. We finally know what…
City Journal
The CDC’s Slender Reed
The Centers for Disease Control and Prevention (CDC) has reversed its guidance from two months ago and now recommends that fully vaccinated…
Blog
Tobacco Control’s Latest Self-Fulfilling Prophecy
If you want to make something irresistible to teenagers, portray it as a forbidden fruit. That is what has happened in the U.S. with…
National Review
The True Meaning of ‘Misinformation’
Last week Senators Amy Klobuchar (D., Minn.) and Ben Ray Luján (D., N.M.) introduced a bill designed to suppress dangerous misinformation about COVID-19 vaccines. Like…
National Review
A Defeat for Dr. Leviathan
A recent ruling by the D.C. Circuit Court of Appeals in a seemingly obscure case has important implications for limits on the Food and Drug…